Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1117656914 | 11176569 | 14 | F | 20150422 | 20160923 | 20150610 | 20160926 | EXP | PHJP2015JP007024 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160926 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1117656914 | 11176569 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 80 MG, QD | U | 21283 | 80 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 2 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, TID | U | 0 | 3 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 3 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 4 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 5 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 6 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 7 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, BID | U | 0 | 1 | MG | TABLET | BID | |||||
1117656914 | 11176569 | 8 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 4 MG, PRN | U | 0 | 4 | MG | TABLET | ||||||
1117656914 | 11176569 | 9 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 2 MG, BID | U | 0 | 2 | MG | TABLET | BID | |||||
1117656914 | 11176569 | 10 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | U | 0 | .5 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 11 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, BID | U | 0 | 1 | MG | TABLET | BID | |||||
1117656914 | 11176569 | 12 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 13 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 14 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, QD | U | 0 | 3 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 15 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 6 MG, QD | U | 0 | 6 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 16 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, QD | U | 0 | 3 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 17 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, TID | U | 0 | 3 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 18 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
1117656914 | 11176569 | 19 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
1117656914 | 11176569 | 20 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, UNK | U | 0 | 3 | MG | TABLET | ||||||
1117656914 | 11176569 | 21 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
1117656914 | 11176569 | 22 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 2 MG, TID | U | 0 | 2 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 23 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 3 MG, UNK | U | 0 | 3 | MG | TABLET | ||||||
1117656914 | 11176569 | 24 | SS | TERNELIN TAB | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TABLET | TID | |||||
1117656914 | 11176569 | 25 | SS | MYONAL | EPERISONE HYDROCHLORIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
1117656914 | 11176569 | 26 | SS | MYONAL | EPERISONE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 27 | C | AMOBAN | ZOPICLONE | 1 | Oral | 7.5 MG, QD | U | 0 | 7.5 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 28 | C | SILECE | FLUNITRAZEPAM | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 29 | C | SILECE | FLUNITRAZEPAM | 1 | U | 0 | TABLET | ||||||||||
1117656914 | 11176569 | 30 | C | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1 | Subcutaneous | UNK | Y | 0 | INJECTION | ||||||||
1117656914 | 11176569 | 31 | C | LEVOTOMIN | LEVOMEPROMAZINE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 32 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
1117656914 | 11176569 | 33 | C | RISPERDAL | RISPERIDONE | 1 | Unknown | UNK UNK, BID | U | 0 | BID | ||||||||
1117656914 | 11176569 | 34 | C | MEILAX | ETHYL LOFLAZEPATE | 1 | Unknown | UNK | U | 0 | |||||||||
1117656914 | 11176569 | 35 | C | LAMICTAL | LAMOTRIGINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1117656914 | 11176569 | 1 | Hypertension |
1117656914 | 11176569 | 2 | Insomnia |
1117656914 | 11176569 | 3 | Musculoskeletal stiffness |
1117656914 | 11176569 | 25 | Product used for unknown indication |
1117656914 | 11176569 | 27 | Insomnia |
1117656914 | 11176569 | 28 | Insomnia |
1117656914 | 11176569 | 29 | Musculoskeletal stiffness |
1117656914 | 11176569 | 30 | Product used for unknown indication |
1117656914 | 11176569 | 31 | Insomnia |
1117656914 | 11176569 | 32 | Blood pressure abnormal |
1117656914 | 11176569 | 33 | Product used for unknown indication |
1117656914 | 11176569 | 34 | Product used for unknown indication |
1117656914 | 11176569 | 35 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1117656914 | 11176569 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1117656914 | 11176569 | Altered state of consciousness | |
1117656914 | 11176569 | Anxiety | |
1117656914 | 11176569 | Arthralgia | |
1117656914 | 11176569 | Asthenia | |
1117656914 | 11176569 | Blood pressure increased | |
1117656914 | 11176569 | Blood pressure systolic decreased | |
1117656914 | 11176569 | Contusion | |
1117656914 | 11176569 | Delirium | |
1117656914 | 11176569 | Dizziness | |
1117656914 | 11176569 | Fall | |
1117656914 | 11176569 | Feeling abnormal | |
1117656914 | 11176569 | Headache | |
1117656914 | 11176569 | Insomnia | |
1117656914 | 11176569 | Ligament sprain | |
1117656914 | 11176569 | Malaise | |
1117656914 | 11176569 | Musculoskeletal pain | |
1117656914 | 11176569 | Musculoskeletal stiffness | |
1117656914 | 11176569 | Overdose | |
1117656914 | 11176569 | Product use issue | |
1117656914 | 11176569 | Somnolence | |
1117656914 | 11176569 | Thirst |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1117656914 | 11176569 | 4 | 20150422 | 0 | ||
1117656914 | 11176569 | 5 | 20150423 | 0 | ||
1117656914 | 11176569 | 6 | 20150511 | 0 | ||
1117656914 | 11176569 | 7 | 20150515 | 0 | ||
1117656914 | 11176569 | 20 | 20160425 | 0 | ||
1117656914 | 11176569 | 21 | 20160426 | 0 | ||
1117656914 | 11176569 | 23 | 20160822 | 0 | ||
1117656914 | 11176569 | 25 | 20150422 | 0 | ||
1117656914 | 11176569 | 30 | 201504 | 0 |